gout hand Arbaclofen extended release tablets (AERT) proved greater tolerability, and similar efficacy and safety, to baclofen in patients with multiple sclerosis (MS), according to randomized trial ...

Arbaclofen extended-release (ER) reduced spasticity in patients with multiple sclerosis and was found to be safe and well-tolerated, according to 2 new abstracts presented at the 33rd Annual Meeting ...

Spasticity is involuntary overactivity of muscles that occurs following upper motor neuron damage to the brain or spinal cord. Upper limb spasticity is common after stroke and can cause deformity, ...

Background: Spasticity is a common and poorly controlled symptom of multiple sclerosis. Our objective was to determine the short-term effect of smoked cannabis on this symptom. Methods: We conducted a ...

Investigators sought to determine the safety and efficacy of twice-daily dosing of arbaclofen ER in patients with spasticity due to multiple sclerosis. SEATTLE – Twice-daily arbaclofen ...

Spasticity is a condition involving an involuntary increase in muscle tone that leads to resistance against normal movements of the body and may cause pain in some individuals. This condition is ...

Almirall S.A. (ALM) today announces that results of the MObility ImproVEments with Spasticity in Multiple Sclerosis (MOVE) 2 observational study performed in Germany, with 300 patients, showed that ...

Intrathecal baclofen (ITB) therapy is an established treatment for severe refractory spasticity. Although a positive ITB ...

Botulinum toxin type A was first used for the treatment of spasticity in 1989. A small uncontrolled study of treatment of upper limb spasticity after stroke reported encouraging benefits, including ...

Spasticity may be a term that’s new to you, but it’s a condition that affects more than 12 million people around the world. [8] It’s a complicated condition, but simply put, it’s extreme muscle ...